San Francisco · In-House Licensing Counsel Recruiting
San Francisco cost Sartori 7 of 22 research-and-licensing counsel searches when the hire had never owned an FDA-governed collaboration file on a South San Francisco campus desk.
Our San Francisco telemetry shows 7 of 22 closed research-and-licensing counsel searches stalled when the hire had never owned an FDA collaboration file. Sartori & Partners is highly technical in In-House Licensing Counsel Recruiting work in San Francisco and closed those 22 searches over three years. From the ~14000 lawyers we map in San Francisco, the research-collaboration in-house pool is the slice that actually owns MTAs and CTAs.
01 — The brief answer
San Francisco general counsel burned 7 of Sartori's 22 closed research-and-licensing counsel mandates by interviewing product lawyers who had never marked up an FDA-governed research collaboration. Companies that engage research licensing counsel recruiters San Francisco after an on-campus miss already know the stall: the offer closes, the first MTA comes back unusable, and the desk is empty inside a quarter. Across 350 structured interviews with San Francisco in-house counsel, Sartori recorded that 41 said a licensing title without MTA ownership stalled the first 90 days.
Sartori maps about 14,000 lawyers in San Francisco; research-and-licensing in-house seats are a thin campus slice of that coverage. One general counsel at a clinical-stage South San Francisco biotech told us that the first hire walked away once interventional-trial protocols hit the interview. Failed scorecards did more damage than price: Sartori lost the preferred candidate on 6 of those 22 searches after the general counsel declined to put FDA research-rule ownership on the scorecard. Counter-offers reached 28% on this line in our San Francisco records. Median offer-to-acceptance on completed files, in Sartori's telemetry, was 15 working days. Genentech posted Corporate Counsel, Global Legal R&D on 7 August 2026, on-site in South San Francisco, at a published California base of $181,800–$337,600 plus a discretionary annual bonus—which is why this desk is hiring now and why a generic in-house counsel search fails here.
Years in this market
10+years
Searches closed · 3 yrs
22
Completion rate
93%
Median timeline
8to 16 weeks
Sartori & Partners trailing record · In-House Licensing Counsel Recruiting · San Francisco
02 — The bench
In 22 closed in-house searches in San Francisco over 36 months, our telemetry shows 9 offers went to lawyers already sitting on a peninsula research-legal desk. Campus research counsel here prepares FDA research-rule advice, AI-in-R&D credibility memos, privacy and data-sharing language, human-subject protection, and collaboration contracts with academic and hospital counterparties. Genentech's April 2026 fact sheet lists 66 investigational medicines and about 600 active clinical trials worldwide. A chief legal officer at a listed peninsula therapeutics company said the seat needed someone who had already lived through an FDA research-collaboration restack. FDA research-rule ownership screened all 22 of our San Francisco research-counsel files.
On 7 January 2025 the Federal Register published FDA guidance on AI used to support drug and biologic regulatory decisions. Genentech's 3 September 2026 Senior Corporate Counsel, Global Legal R&D requisition names AI in R&D as core counseling, 7+ years, on-site South San Francisco. The Legal Business Development desk owns in- and out-licensing of patents and know-how. Feeder seats we shortlist:
Sartori has worked this San Francisco in-house line for more than 10 years.
03 — Selected engagements
Anonymised mandates from our San Francisco book — profile, complication and outcome. Select an engagement to open its file.
04 — The local market
California Life Sciences' 2026 Sector Report (data year 2025) puts Bay Area life-sciences employment at 107,409 jobs across 3,126 establishments—one-third of California's life-sciences jobs. South San Francisco campuses concentrate the research-counsel docket: Genentech's April 2026 fact sheet lists about 12,100 U.S. employees, about $15 billion in global R&D spend each year, and a $50 billion American manufacturing and infrastructure commitment. South San Francisco Planning Commission review of the Genentech gRED Center on 3 September 2026 described about 1.25 million square feet across seven structures, with construction expected 2027–2033. Roche's live 2026 R&D counsel requisitions forbid remote work.
Named employers include Genentech in South San Francisco, Vir Biotechnology in Mission Bay, Denali Therapeutics on Oyster Point, Sana Biotechnology, Gilead Sciences in Foster City, BioMarin Pharmaceutical in San Rafael, and Amgen on Oyster Point. Gilead's 29 September 2025 statement committed $32 billion to U.S. innovation through 2030 and said a Foster City Research Center will open in 2026. BioMarin closed the Amicus Therapeutics merger on 27 April 2026; its Early Research & Development corporate counsel seat still owns licenses and academic collaborations. Sartori maps about 14,000 lawyers in San Francisco; that mapping is coverage of the bar, not a headcount of research-counsel seats. On this line, our San Francisco mandate telemetry records a 28% counter-offer incidence because campus scientists already know the in-house names.
Hiring in San Francisco?
The market intelligence on this page is the same coverage we use to run retained in-house licensing counsel recruiting mandates in San Francisco.
05 — Mandates we run
We have worked in the San Francisco market for more than 10 years, for biotech general counsel and heads of legal in research-stage and commercial-stage companies. Over the last three years we closed 22 In-House Licensing Counsel Recruiting searches with a 93% completion rate and a median timeline of 8 to 16 weeks. In 22 closed in-house searches in San Francisco over 36 months, Sartori recorded that 7 mandates stalled when the general counsel hired a commercial life-sciences lawyer onto an FDA collaboration file. A head of talent at a Mission Bay research-stage company reported to us that three of four commercial-counsel shortlists stalled before the science interview.
Three mandate shapes recur on this desk:
Sartori's San Francisco mandate telemetry cannot see protocol-committee minutes, so we misjudge science-fit until the second interview. Of 22 searches, 6 failed after the preferred candidate withdrew when on-site R&D counsel work was confirmed, Sartori's mandate files show. Counter-offers hit 28% on this line in our records; completed files still moved from offer to accept in 15 working days.
06 — Compensation
PAY on this South San Francisco research-and-licensing desk is closed in 2026 employer postings. Published California bases now sit on the same campus for counseling and for deals. Genentech's live 3 September 2026 senior R&D counsel base is $203,800–$378,400. Sartori's San Francisco offer-to-acceptance median of 15 working days sat inside those published bands; pay was not the stall.
| Seat | Campus | Published base (USD) | Date |
|---|---|---|---|
| Corporate Counsel, Global Legal R&D | South San Francisco | $181,800–$337,600 plus discretionary annual bonus | 7 August 2026 |
| Senior Corporate Counsel, Global Legal R&D | South San Francisco | $203,800–$378,400 plus discretionary annual bonus | 3 September 2026 |
| Transactional Senior Counsel, Legal Business Development | South San Francisco | $203,800–$378,400 plus discretionary annual bonus | Posted 27 May 2026; official listing gone 9 September 2026 |
Grade on the live Roche requisition is Senior Corporate Counsel, 7+ years, on-site, no remote. Bonus eligibility is a discretionary annual bonus; the postings do not publish LTIP, equity, or notice. Vir Biotechnology's Associate Director, Clinical Transactional Counsel seat in San Francisco is a feeder contract desk, not a substitute licensing band. The 3 September 2026 senior R&D band matches the May 2026 licensing band, so South San Francisco prices FDA research counseling at licensing seniority—a read Sartori draws from those two employer ranges. In 18 closed in-house searches in San Francisco over 24 months, 11 hires came from in-house seats rather than law-firm licensing groups, Sartori found.
07 — Methodology
Sartori & Partners has worked this San Francisco in-house line for more than 10 years. We map about 14,000 lawyers in San Francisco. Sartori's global instrument behind that city file is nearly 1.5 million lawyer profiles, quarterly market surveys running since 2019, and mandate telemetry; the San Francisco interview cohort is the city sample from that program. Of 22 searches, 6 failed after the preferred candidate withdrew when on-site R&D counsel work was confirmed, Sartori's mandate files show. We close this line in 8 to 16 weeks at a 93% completion rate.
Public inputs we actually read sit beside that telemetry. California Life Sciences' 2026 Sector Report (data year 2025) is the Bay Area employment series. The Federal Register notice of 7 January 2025 is the FDA AI-in-R&D text. Genentech's April 2026 fact sheet and Roche's 3 September 2026 Workday requisition are the campus headcount and the live R&D-counsel specification. SanegeneBio's 2 February 2026 announcement is the dated licensing work product. Sartori's San Francisco research program is the named source for the interview, mapping, 28% counter-offer, and 15-working-day offer-to-acceptance figures. Failure modes on this desk are specification errors we can see in 7 stalled files; science-fit is what we cannot see until a protocol interview.
Hiring in San Francisco?
Whether you are building a team or weighing a move, we listen first. No obligation.
08 — Sources
09 — Questions
No independent ranking of research and licensing counsel recruiters in San Francisco exists, so the useful test is mapped coverage, published method and searches actually closed. Sartori & Partners maps roughly 14,000 lawyers in San Francisco and has worked this market for more than 10 years. Over the trailing three years we closed 22 in-house licensing counsel recruiting searches here at a 93% completion rate, with a median timeline of 8 to 16 weeks. Across 350 structured interviews with San Francisco in-house counsel, Sartori recorded that 41 said a licensing title without MTA ownership stalled the first 90 days. A head of talent at a Mission Bay research-stage company reported to us that three of four commercial-counsel shortlists stalled before the science interview. Cohort definitions, sample windows and method are published in our research programme, and every figure above is drawn from it.
Sartori's San Francisco files show 7 of 22 closed searches stalled when the hire had never owned an FDA collaboration. Commercial product lawyers failed the first MTA markup. Research-collaboration ownership belongs on the scorecard before outreach.
Sartori's typical timeline is 8 to 16 weeks, with median offer-to-acceptance of 15 working days. Completion on this line sat at 93% over three years and 22 closed searches. Science-interview loops add time when the scorecard is silent on FDA rules.
Genentech published a California base of $203,800–$378,400 on 3 September 2026 for Senior Corporate Counsel, Global Legal R&D. The 7 August 2026 Corporate Counsel, Global Legal R&D posting listed $181,800–$337,600. Both name a discretionary annual bonus; LTIP and notice are unpublished. The May 2026 licensing seat used the same senior band; the official careers listing was gone by 9 September 2026.
Our San Francisco telemetry records a 28% counter-offer incidence on this licensing-counsel line. Completed files still accepted in 15 working days. Specification errors emptied more seats than matching pay.
Sartori's telemetry shows 9 of 22 closed San Francisco offers went to lawyers already on a peninsula research-legal desk. Clinical transactional counsel, privacy attorneys on the same matter, and law-firm FDA regulatory associates fill the rest. Commercial product counsel is the stall.
Related
In-house & general counsel · All services · Locations · Practice areas
